The experience of using ataluren in Duchenne muscular dystrophy in Moscow: first results
Duchenne muscular dystrophy (DMD) is an X-linked inherited neuromuscular disorder typically manifesting in boys aged 2–5 years, characterized by a progressive course. According to natural disease progression data, individuals with DMD typically lose the ability to walk independently by the age of 13...
Saved in:
Main Authors: | T. N. Kekeeva, N. L. Pechatnikova, I. P. Vitkovskaya, V. S. Kakaulina, N. A. Krasnoschekova, Yu. E. Martynenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2024-01-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/573 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive experience in treating patients with Duchenne muscular dystrophy caused by a nonsense mutation: family clinical case
by: L. S. Kraeva, et al.
Published: (2024-09-01) -
Dynamics of the course of Duchenne muscular dystrophy in patients taking ataluren and concomitant drug and non-drug therapy
by: V. M. Suslov, et al.
Published: (2024-01-01) -
Assessment of walking in patients with Duchenne muscular dystrophy receiving ataluren in real clinical practice
by: D. V. Aizatulina, et al.
Published: (2025-04-01) -
Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
by: Anna Teresa Michalska, et al.
Published: (2025-07-01) -
Computer task performance by subjects with Duchenne muscular dystrophy
by: Malheiros SR, et al.
Published: (2015-12-01)